Form 4: Integrated BioPharma Director Acquires Shares Through Option Exercise
SEC Form 4 Filing
Director Robert Canarick acquired 175,000 shares of Integrated BioPharma Inc. through the exercise of stock options at $0.09 per share.
Summary
- On May 21, 2025, Robert Canarick, a director of Integrated BioPharma Inc. (INBP), acquired 175,000 shares of common stock.
- The acquisition was made through the exercise of stock options.
- The price per share was $0.09.
- Following the transaction, Canarick directly owns 234,233 shares of Integrated BioPharma Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction. The director exercising options at $0.09 could be seen as a slightly positive signal, but it's not a major event.
Positives
- A director exercising options can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a standard disclosure related to insider trading. It doesn't provide specific insight into the broader industry trends.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/02/2015 | Date of stock option grant. |
| 07/02/2015 | Start date for monthly installments of option vesting. |
| 05/21/2025 | Date of transaction: acquisition of shares through option exercise. |
| 05/22/2025 | Date of signature on the Form 4. |
Keywords
stock options, director, INBP, Integrated BioPharma Inc., share acquisition, Form 4, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.